Use of SMS texts for facilitating access to online alcohol interventions: a feasibility study

A41 Use of SMS texts for facilitating access to online alcohol interventions: a feasibility study In: Addiction Science & Clinical Practice 2017, 12(Suppl 1): A4

The Genesis solar-wind collector materials

Genesis (NASA Discovery Mission #5) is a sample return mission. Collectors comprised of ultra-high purity materials will be exposed to the solar wind and then returned to Earth for laboratory analysis. There is a suite of fifteen types of ultra-pure materials distributed among several locations. Most of the materials are mounted on deployable panels (`collector arrays'), with some as targets in the focal spot of an electrostatic mirror (the `concentrator'). Other materials are strategically placed on the spacecraft as additional targets of opportunity to maximize the area for solar-wind collection. Most of the collection area consists of hexagonal collectors in the arrays; approximately half are silicon, the rest are for solar-wind components not retained and/or not easily measured in silicon. There are a variety of materials both in collector arrays and elsewhere targeted for the analyses of specific solar-wind components. Engineering and science factors drove the selection process. Engineering required testing of physical properties such as the ability to withstand shaking on launch and thermal cycling during deployment. Science constraints included bulk purity, surface and interface cleanliness, retentiveness with respect to individual solar-wind components, and availability. A detailed report of material parameters planned as a resource for choosing materials for study will be published on a Genesis website, and will be updated as additional information is obtained. Some material is already linked to the Genesis plasma data website (genesis.lanl.gov). Genesis should provide a reservoir of materials for allocation to the scientific community throughout the 21st Century

Radiation-induced Activation of Nuclear Factor-κB Involves Selective Degradation of Plasma Membrane-associated IκBα

In contrast to nuclear factor-κB (NF-κB) activation by tumor necrosis factor-α (TNF-α), the specific processes involved in the activation of this transcription factor by ionizing radiation (IR) have not been completely defined. According to the classical paradigm, a critical event in NF-κB activation is the degradation of IκBα. Data presented herein show that, in contrast to treatment with TNF-α, IR-induced NF-κB activation was not accompanied by degradation of IκBα in the U251 glioblastoma cell line as determined in whole cell lysates. However, treatment with the proteosome inhibitor MG-132 inhibited NF-κB activation induced by IR, suggesting that IκBα degradation was a critical event in this process. To reconcile these results, U251 cell lysates were separated into soluble and insoluble fractions and IκBα levels evaluated. Although IκBα was found in both subcellular fractions, treatment with IR resulted in the degradation of IκBα only in the insoluble fraction. Further subcellular fractionation suggested that the IR-sensitive, insoluble pool of IκBα was associated with the plasma membrane. These data suggest that the subcellular location of IκBα is a critical determinant in IR-induced NF-κB activation

Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort

OBJECTIVES: The Social Appearance Anxiety Scale (SAAS) is a 16-item measure that assesses social anxiety in situations where appearance is evaluated. The objective was to use optimal test assembly (OTA) methods to develop and validate a short-form SAAS based on objective and reproducible criteria. DESIGN: This study was a cross-sectional analysis of baseline data from adults enrolled in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. SETTING: Adults in the SPIN Cohort in the present study were enrolled at 28 centres in Canada, the USA and the UK. PARTICIPANTS: The SAAS was administered to 926 adults with scleroderma. PRIMARY AND SECONDARY MEASURES: The SAAS, Brief Fear of Negative Evaluation II (BFNE II), Brief Satisfaction with Appearance Scale (Brief-SWAP), Patient Health Questionnaire-8 (PHQ8) and Social Interaction Anxiety Scale-6 (SIAS-6) were collected, as well as demographic characteristics. RESULTS: OTA methods identified a maximally informative shortened version for each possible form length between 1 and 15 items. The final shortened version was selected based on prespecified criteria for reliability, concurrent validity and statistically equivalent convergent validity with the BFNE II scale. A five-item short version was selected (SAAS-5). The SAAS-5 had a Cronbach's α of 0.95 and had high concurrent validity with the full-length form (r=0.97). The correlation of the SAAS-5 with the BFNE II was 0.66, which was statistically equivalent to that of the full-length form. Furthermore, the correlation of the SAAS-5 with the two subscales of the Brief-SWAP, and the SIAS-6, were statistically equivalent to that of the full-length form. CONCLUSIONS: OTA was an efficient method for shortening the full-length SAAS to create the SAAS-5